Skip to Content
MilliporeSigma
All Photos(1)

Documents

Z226238

Nucleosil® C8 HPLC Column

5 μm particle size, L × I.D. 25 cm × 4.6 mm

Synonym(s):

Octyl Silica Column

Sign Into View Organizational & Contract Pricing


About This Item

UNSPSC Code:
41115700
eCl@ss:
32110501
NACRES:
SB.52

agency

suitable for USP L7

Quality Level

product line

Nucleosil®

feature

endcapped: no

manufacturer/tradename

Nucleosil®

extent of labeling

8.5% Carbon loading

parameter

400 bar pressure (5801 psi)

technique(s)

HPLC: suitable

L × I.D.

25 cm × 4.6 mm

surface area

350 m2/g

matrix

octyl

matrix active group

C8 (octyl) phase

particle size

5 μm

pore size

100 Å

separation technique

reversed phase

Looking for similar products? Visit Product Comparison Guide

Related Categories

Application


  • Determination of melamine in milk and dairy products by high performance liquid chromatography.: This study describes the use of the Nucleosil® C8 HPLC column for determining melamine contamination in dairy products, highlighting its efficiency in food safety applications (Filazi et al., 2012).

  • Validation of a novel, fully automated high throughput high-performance liquid chromatographic/tandem mass Spectrometric method for quantification of pantoprazole in human plasma.: Utilizes Nucleosil® C8 HPLC column to establish a rapid and reliable method for plasma analysis in clinical pharmacokinetic studies (Dotsikas et al., 2010).

  • Simultaneous determination of alprazolam and fluoxetine hydrochloride in tablet formulations by high-performance column liquid chromatography and high-performance thin-layer chromatography.: Demonstrates the versatility of Nucleosil® C8 columns in pharmaceutical analysis, ensuring precise quantification in complex matrices (Patel et al., 2009).

  • Simultaneous estimation of acetylsalicylic acid and clopidogrel bisulfate in pure powder and tablet formulations by high-performance column liquid chromatography and high-performance thin-layer chromatography.: Features the application of Nucleosil® C8 in dual-drug analysis, proving its capability in simultaneous analytical tasks (Patel et al., 2008).

  • Validated HPLC method for determination of amlodipine in human plasma and its application to pharmacokinetic studies.: This research highlights the column′s role in the pharmacokinetic evaluation of cardiovascular drugs, underscoring its reliability and reproducibility (Zarghi et al., 2005).

Recommended products

Discover LiChropur reagents ideal for HPLC or LC-MS analysis

Legal Information

Nucleosil is a registered trademark of Macherey-Nagel GmbH & Co. KG

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Sorry, we don't have COAs for this product available online at this time.

If you need assistance, please contact Customer Support.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service